New hope for calming Alzheimer's agitation

NCT ID NCT05557409

Completed Symptom relief Sponsor: Axsome Therapeutics, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested whether the medication AXS-05 could safely reduce agitation in people with Alzheimer's disease. 408 participants with Alzheimer's-related agitation were randomly assigned to receive either the drug or a placebo for 5 weeks. Researchers measured changes in agitation levels to see if the treatment was effective.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Clinical Research Site

Peoria, Arizona, 85381, United States
Clinical Research Site

Tempe, Arizona, 85282, United States
Clinical Research Site

Tucson, Arizona, 85710, United States
Clinical Research Site

Canoga Park, California, 91303, United States
Clinical Research Site

Long Beach, California, 90807, United States
Clinical Research Site

Los Alamitos, California, 90720, United States
Clinical Research Site

Walnut Creek, California, 94596, United States
Clinical Research Site

West Covina, California, 91790, United States
Clinical Research Site

Bonita Springs, Florida, 34134, United States
Clinical Research Site

Brandon, Florida, 33511, United States
Clinical Research Site

Greenacres City, Florida, 33467, United States
Clinical Research Site

Hialeah, Florida, 33012, United States
Clinical Research Site

Hollywood, Florida, 33024, United States
Clinical Research Site

Kissimmee, Florida, 34741, United States
Clinical Research Site

Miami, Florida, 33126, United States
Clinical Research Site

Miami, Florida, 33135, United States
Clinical Research Site

Miami, Florida, 33145, United States
Clinical Research Site

Miami, Florida, 33155, United States
Clinical Research Site

Miami, Florida, 33165, United States
Clinical Research Site

Miami, Florida, 33173, United States
Clinical Research Site

Miami, Florida, 33175, United States
Clinical Research Site

Miami Gardens, Florida, 33014, United States
Clinical Research Site

Miami Lakes, Florida, 33014, United States
Clinical Research Site

Orlando, Florida, 32807, United States
Clinical Research Site

Pembroke Pines, Florida, 33025, United States
Clinical Research Site

Tampa, Florida, 33614, United States
Clinical Research Site

Tampa, Florida, 33634, United States
Clinical Research Site

Augusta, Georgia, 30912, United States
Clinical Research Site

College Park, Georgia, 30349, United States
Clinical Research Site

Columbus, Georgia, 31909, United States
Clinical Research Site

Wichita, Kansas, 67214, United States
Clinical Research Site

Marrero, Louisiana, 70072, United States
Clinical Research Site

Braintree, Massachusetts, 02184, United States
Clinical Research Site

Flint, Michigan, 48532, United States
Clinical Research Site

Rochester Hills, Michigan, 48307, United States
Clinical Research Site

Troy, Michigan, 48085, United States
Clinical Research Site

Chesterfield, Missouri, 63005, United States
Clinical Research Site

Berlin, New Jersey, 08009, United States
Clinical Research Site

Toms River, New Jersey, 08755, United States
Clinical Research Site

Brooklyn, New York, 11229, United States
Clinical Research Site

New Windsor, New York, 12553, United States
Clinical Research Site

Staten Island, New York, 10312, United States
Clinical Research Site

Woodmere, New York, 11598, United States
Clinical Research Site

Charlotte, North Carolina, 28211, United States
Clinical Research Site

Hickory, North Carolina, 28601, United States
Clinical Research Site

Middleburg Heights, Ohio, 44130, United States
Clinical Research Site

Austin, Texas, 78737, United States
Clinical Research Site

Cypress, Texas, 77429, United States
Clinical Research Site

Mesquite, Texas, 75149, United States
Clinical Research Site

San Antonio, Texas, 78229, United States
Clinical Research Site

Sugar Land, Texas, 77478, United States
Clinical Research Site

Rutland, Vermont, 05701, United States
Clinical Research Site

Arlington, Virginia, 22205, United States
Clinical Research Site

Bayamón, 00961, Puerto Rico
Clinical Research Site

San Juan, 00918, Puerto Rico

Conditions

Explore the condition pages connected to this study.

AGITATION AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE ALZHEIMER DISEASE